As the United States stock markets reach record highs following Donald Trump's recent election victory, investors are closely examining potential opportunities amidst the surge. In this buoyant environment, identifying stocks that may be trading below their estimated value can offer a strategic advantage for those looking to capitalize on market dynamics.
Name | Current Price | Fair Value (Est) | Discount (Est) |
NBT Bancorp (NasdaqGS:NBTB) | $50.79 | $99.93 | 49.2% |
UMB Financial (NasdaqGS:UMBF) | $125.68 | $243.52 | 48.4% |
Synovus Financial (NYSE:SNV) | $58.47 | $114.84 | 49.1% |
West Bancorporation (NasdaqGS:WTBA) | $24.35 | $46.56 | 47.7% |
Alnylam Pharmaceuticals (NasdaqGS:ALNY) | $273.01 | $545.05 | 49.9% |
STAAR Surgical (NasdaqGM:STAA) | $30.86 | $59.97 | 48.5% |
Snap (NYSE:SNAP) | $11.81 | $22.86 | 48.3% |
AeroVironment (NasdaqGS:AVAV) | $216.32 | $416.09 | 48% |
Carter Bankshares (NasdaqGS:CARE) | $20.00 | $38.28 | 47.8% |
Rapid7 (NasdaqGM:RPD) | $41.60 | $80.91 | 48.6% |
Click here to see the full list of 196 stocks from our Undervalued US Stocks Based On Cash Flows screener.
Underneath we present a selection of stocks filtered out by our screen.
Overview: HealthEquity, Inc. operates as a technology-enabled services platform offering solutions to consumers and employers in the United States, with a market cap of approximately $7.79 billion.
Operations: HealthEquity generates revenue from its Pharmacy Services segment, which amounted to $1.10 billion.
Estimated Discount To Fair Value: 44.1%
HealthEquity is trading significantly below its estimated fair value, with a share price of US$97.95 against a fair value estimate of US$175.13. Despite recent insider selling, the company reported strong earnings growth, with net income rising to US$35.82 million in Q2 2024 from US$10.58 million the previous year. Revenue is forecast to grow faster than the market at 11.4% annually, supported by innovative initiatives like HSAnswers and strategic financial maneuvers such as a new credit facility and share repurchase program.
Overview: Moog Inc. designs, manufactures, and integrates precision motion and fluid controls systems for aerospace, defense, and industrial markets globally, with a market cap of approximately $6.39 billion.
Operations: The company's revenue segments include Industrial at $991.15 million, Military Aircraft at $811.57 million, Space and Defense at $1.02 billion, and Commercial Aircraft at $788.30 million.
Estimated Discount To Fair Value: 38%
Moog is trading well below its estimated fair value of US$365.41, with a current price of US$226.58, highlighting potential undervaluation based on cash flows. Despite high debt levels, Moog's earnings are projected to grow significantly at 20.2% annually over the next three years, outpacing the broader U.S. market's growth rate. Recent results show an increase in annual net income to US$207.22 million and a new product line launch could support future revenue streams.
Overview: Synovus Financial Corp. operates as the bank holding company for Synovus Bank, offering commercial and consumer banking products and services, with a market cap of $7.05 billion.
Operations: Synovus Financial Corp.'s revenue is primarily generated from its Consumer Banking segment at $634.05 million, Community Banking at $467.19 million, Wholesale Banking at $800.47 million, and Financial Management Services (FMS) contributing $281.44 million.
Estimated Discount To Fair Value: 49.1%
Synovus Financial is trading at a significant discount, with its current price of US$58.47 below the estimated fair value of US$114.84, indicating potential undervaluation based on cash flows. The company recently completed a $500 million fixed-income offering to strengthen its financial position. Despite lower profit margins compared to last year, earnings are expected to grow by 33% annually over the next three years, outpacing the U.S. market's growth rate.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGS:HQY NYSE:MOG.A and NYSE:SNV.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。